{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioavailability+Study&page=36", "query": { "condition": "Bioavailability Study", "page": 36 }, "page_size": 10 }, "pagination": { "page": 36, "page_size": 10, "total_count": 1099, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioavailability+Study&page=37&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioavailability+Study&page=35&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T15:08:31.206Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00835354", "title": "Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Cefprozil for oral suspension 250 mg/5 mL", "type": "DRUG" }, { "name": "CEFZIL® for Oral Suspension 250 mg/5mL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2004-05", "completion_date": "2004-05", "has_results": true, "last_update_posted_date": "2024-08-20", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 2, "location_summary": "Saint Charles, Missouri • Houston, Texas", "locations": [ { "city": "Saint Charles", "state": "Missouri" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00835354" }, { "nct_id": "NCT00853554", "title": "Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Hydromorphone Hydrochloride tablet 8 mg", "type": "DRUG" }, { "name": "Dilaudid® tablet 8 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2002-12", "completion_date": "2002-12", "has_results": false, "last_update_posted_date": "2016-10-19", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853554" }, { "nct_id": "NCT00932763", "title": "Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Amlodipine besylate", "type": "DRUG" }, { "name": "Norvasc", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Torrent Pharmaceuticals Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2009-07-17", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00932763" }, { "nct_id": "NCT04991571", "title": "Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "Zibotentan (Treatment A)", "type": "DRUG" }, { "name": "Dapagliflozin (Treatment A)", "type": "DRUG" }, { "name": "Zibotentan/Dapagliflozin - Formulation 1 (Treatment B)", "type": "DRUG" }, { "name": "Zibotentan/Dapagliflozin - Formulation 2 (Treatment C)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 27, "start_date": "2021-07-29", "completion_date": "2021-10-22", "has_results": false, "last_update_posted_date": "2021-11-23", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Brooklyn, Maryland", "locations": [ { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04991571" }, { "nct_id": "NCT01261481", "title": "Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Tolvaptan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 29, "start_date": "2011-01", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2012-12-07", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01261481" }, { "nct_id": "NCT00844207", "title": "A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malaria" ], "interventions": [ { "name": "Fixed combination of Azithromycin and Chloroquine", "type": "DRUG" }, { "name": "Azithromycin and Chloroquine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2009-02", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2009-04-21", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00844207" }, { "nct_id": "NCT01365000", "title": "Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "NKTR118 Formulation 1", "type": "DRUG" }, { "name": "NKTR118 Formulation 2", "type": "DRUG" }, { "name": "NKTR118 Formulation 3", "type": "DRUG" }, { "name": "NKTR118 Formulation 1a", "type": "DRUG" }, { "name": "NKTR118 Formulation 3a", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 21, "start_date": "2011-06", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2014-10-15", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01365000" }, { "nct_id": "NCT00834795", "title": "Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Carvedilol 25 mg tablets", "type": "DRUG" }, { "name": "COREG® 25 mg tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2001-12", "completion_date": "2001-12", "has_results": true, "last_update_posted_date": "2024-08-19", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00834795" }, { "nct_id": "NCT06098001", "title": "Bioavailability Study of Hemp Phenolics", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bioavailability", "Metabolites", "Excretion" ], "interventions": [ { "name": "Low dose dietary fiber", "type": "DIETARY_SUPPLEMENT" }, { "name": "High dose dietary fiber", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Brightseed", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 10, "start_date": "2023-09-15", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2023-10-24", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Addison, Illinois", "locations": [ { "city": "Addison", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06098001" }, { "nct_id": "NCT00864344", "title": "A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Sertraline HCl 100 mg tablets, single dose", "type": "DRUG" }, { "name": "Zoloft® 100 mg tablets, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 30, "start_date": "2004-08", "completion_date": "2004-08", "has_results": false, "last_update_posted_date": "2010-08-16", "last_synced_at": "2026-10-29T15:08:31.206Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864344" } ] }